The firm has “Market Perform” rating given on Thursday, April 7 by BMO Capital Markets. Finally, Leerink Swann restated a “buy” rating on shares of Alexion Pharmaceuticals in a report on Tuesday, May 23rd. Analysts mean recommendation for the stock is 2.80. The rating was maintained by Cantor Fitzgerald on Thursday, January 14 with “Buy”. 660,779 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is a huge mover today! About 397,954 shares traded.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is worth US$31.08 Billion and has recently risen 1.08% to US$139.02. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data. (NASDAQ:ALXN) has been trading recently.
Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)’s stock has been 5.92% and 7.24% for the last 12 months. Therefore 73% are positive. Alexion Pharmaceuticals, Inc. has had earnings per share growth of 14.00% over the past five years. Partner Fund Mgmt LP invested 0.46% of its portfolio in Alexion Pharmaceuticals, Inc. The firm earned “Strong Buy” rating on Tuesday, September 1 by Raymond James. On May 25 the company was upgraded from “Equal-Weight” to “Overweight” in a report issued by Morgan Stanley. The company was maintained on Thursday, July 27 by Stifel Nicolaus.
04/06/2015 – Achillion Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. Six analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. 8 of them rate its stock a hold.
Stock of Senseonics Holdings, Inc. (ALXN) opened at 137.54 on Friday. Brean Capital has “Buy” rating and $221 target.
Since February 27, 2017, it had 4 insider purchases, and 2 insider sales for $235.66 million activity. 835 shares were sold by PARVEN ALVIN S, worth $97,511. On Thursday, March 2 the insider O’Neill Julie sold $87,104. Thomas J Herzfeld Advisors reported 152 shares. The Healthcor Management Lp holds 261,140 shares with $31.95 million value, down from 650,000 last quarter. Shares for $1.17M were bought by HANTSON LUDWIG. Blackrock Mngmt Ltd Liability Corp has invested 0.33% in Alexion Pharmaceuticals, Inc. The company has market cap of $233.93 million. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. It has a 60.65 P/E ratio. The Business’s products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).
Investors sentiment increased to 1.37 in Q4 2016. The biopharmaceutical company reported $1.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.48.
Market capitalization is the total market value of all of a company’s outstanding shares. Amf Pensionsforsakring Ab reported 282,406 shares. Finally, Geneva Advisors LLC raised its stake in Alexion Pharmaceuticals by 0.7% in the second quarter. Citigroup upgraded Alexion Pharmaceuticals, Inc. That suggests something of the likelihood of a short squeeze in shares of ALXN.
Is Copart, Inc. (NASDAQ:CPRT) Cheap From Peers? (NASDAQ:ALXN) rating on Thursday, July 27.
Analyst Thoughts About Copart, Inc.
Tourbillon Capital Partners Lp increased Expedia Inc Del (NASDAQ:EXPE) stake by 1.03 million shares to 1.80M valued at $204.30 million in 2016Q4. (NASDAQ:ALXN). Principal Fin Group owns 326,273 shares for 0.05% of their portfolio. The lower end of the projection is $1.23 per share, while the higher end is $1.48 per share. Twin Cap reported 24,100 shares. Sun Life Fin holds 0% or 15 shares. Factory Mutual Insur Com, a Massachusetts-based fund reported 23,000 shares. Rockefeller Fincl Incorporated has 9,257 shares. Services Automobile Association reported 169,002 shares. (NASDAQ:VLGEA). Geode Management Ltd Liability Corporation invested 0% of its portfolio in Village Super Market, Inc. The Firm operates through Moss Bros branded mainstream stores. Over the long run, the price of a stock will generally go up in lock step with its earnings (assuming the P/E ratio is constant). The Company’s divisions include Retail and Hire.
Latest analyst recommendations could offer little help to investors.